Santoro A, Improta CM, Sarina B, Mannina D, et al. Brentuximab vedotin plus nivolumab as bridging therapy to CAR T-cells in relapsed/refractory primary mediastinal B-cell lymphoma. Haematologica 2025 Sep 18. doi: 10.3324/haematol.2025.287672.
PMID: 40963380